Defiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.

In today's episode of "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Mydecine (MYCO/MYCOF), Numinuss Wellness (NUMI), and Red Light Holland (TRIP). We will cover the latest developments in the field writ large. This means we will cover any stories that affect the all the companies in this field, as well as company specific developments. Time Stamps 0:00​ - Intro 0:35 - Imperial College Of London results of Study the effects of microdosing psychedelics and their impact on the psychedelic industry 5:45 - 15 Canadian healthcare professionals begin a historic psilocybin training program 6:55 - Chief of the Defense Force, Chris Barrie, is calling for psychedelic compounds like psilocybin and MDMA to be rescheduled 8:31 - A smartphone app called promises to induce a psychedelic like state (FUN)! 10:58 - MindMmed Stock News ( MMED/MMEDF/MMQ) and Company Updates 13:33 - Compass Pathways (CMPS) Stock News and Company Updates 15:22 - Atai Life Sciences Company News and IPO Speculation 16:42 - Numinus (NUMI) Stock News & 3 Company Updates 19:30 -Red Light Holland (TRIP) Stock News & Very Interesting Company Update 20:52 - Mydecine (MYCO/MYCOF) Stock News & Updates So this is it for This Week in Psychedelic Stocks fellow psychedelic investors! I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed​​ ​#MindmedStock​​ #PsychedelicStocks

This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.